Awarene T PF Eye Drop

Awarene T PF Eye Drop has a combination of two medicines used to treat glaucoma and ocular hypertension. It decreases the fluid (aqueous humor) production in the eye, which relieves the pressure in the eye.

Awarene T PF Eye Drop is to be used only in the affected eye. Use it in the dose and duration as advised by the doctor. Wash your hands before using this medicine. Check the label thoroughly for directions before use. Do not skip any doses and finish the full course of treatment even if you feel better.

Use of this medicine may cause a burning sensation, stinging, and irritation at the application site. It may also cause eye pain, itching in the eye, and altered taste. These are usually temporary and resolve with time. However, if they persist or get worse, inform your doctor. In case of accidental contact with your ears, nose, or mouth, immediately rinse them with water.

Inform your doctor if you have a known allergy to any of the ingredients in this medicine or if you are taking any other medication. It is advised not to drive or operate heavy machinery immediately after using this medicine, as it may cause temporary blurring of vision and may affect your ability to drive.

Treatment of Glaucoma

Treatment of Ocular hypertension

This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off the extra liquid.

Awarene T PF Eye Drop is a combination of two medicines: Timolol and Travoprost. Timolol is a beta blocker while Travoprost is a prostaglandin analogue. They work by decreasing the production of aqueous humor (fluid in the eye), thereby lowering the increased eye pressure.

Q: What if you forget to take Awarene T PF Eye Drop?
A: If you miss a dose of Awarene T PF Eye Drop, skip it and continue with your normal schedule. Do not double the dose.

To avoid contamination, do not touch the tip of the medicine or let it touch your eye or any other surface.

After applying Awarene T PF Eye Drop, close your eyes, and place one finger at the corner of your eye. Apply gentle pressure for 1 to 2 minutes before opening your eyes. This will prevent the medication from draining out.

Wait for at least 5-10 minutes before delivering the next medication in the same eye to avoid dilution.

Make sure to use it within 4 weeks of opening the bottle.

In Treatment of Glaucoma

Glaucoma is an eye disease that damages the optic nerve which is essential for proper vision. This damage is often caused by an abnormally high pressure in the eye. Awarene T PF Eye Drop is used to reduce swelling and pressure inside the eye. This helps prevent complications of glaucoma such as blindness and improves the vision. This medicine may be used alone or with other eye drops. Glaucoma cannot be prevented. Frequent monitoring, regular checkups can help detect the disease in its early stages.

Ocular hyperemia

Punctate keratitis

Blurred vision

Dry eye

Eye pain

Eye itching

Eye discomfort

Eye irritation

Alcohol:

No interaction found/established

Pregnancy:CONSULT YOUR DOCTOR

Awarene T PF Eye Drop may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding:CAUTION

Awarene T PF Eye Drop should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.

Driving:UNSAFE

Awarene T PF Eye Drop may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear..

Kidney:

No interaction found/established

Liver:

No interaction found/established

Timolol maleate + travoprost [EMC Label]. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2006 [revised 31 May 2018]. [Accessed 15 Apr. 2019] (online) Available from: View
Travoprost + Timolol [Product Information]. Dublin 4, Ireland: Novartis Europharm Limited; 2006 [revised 07 Oct. 2010]. [Accessed 15 Apr. 2019] (online) Available from: View
Travoprost and timolol ophthalmic solution [Product Monograph]. Boucherville, QC, Canada: Sandoz Canada Inc.; 2018. [Accessed 28th Sept. 2023] (online) Available from: View
Travoprost and Timolol Maleate [Product Monograph]. Basel, Switzerland: Novartis; 2020. [Accessed 13 Mar. 2025] (online) Available from: View